查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1760030

2025年生物技术人工智慧全球市场报告

AI In Biotechnology Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年，生物技术领域的人工智慧市场规模将呈指数级增长。到 2029 年，该市场规模将成长至 134 亿美元，复合年增长率为 24.6%。预测期内的成长可以归因于人工智慧技术的普及、人工智慧生物企业投资的增加、人工智慧在毒理学研究中的应用不断增长、人工智慧主导的癌症研究中预测模型的出现，以及人工智慧主导的药物再利用领域的扩展。这段时期预计的主要趋势包括深度学习和神经网路的发展、人工智慧与基因组学和蛋白​​质组学的整合、人工智慧主导的CRISPR 基因编辑的进步、人工智慧在药物安全检测中的应用，以及基于人工智慧的伴随诊断的开发。

人工智慧 (AI) 的日益普及预计将推动生物技术领域 AI 市场的扩张。 AI 指的是模拟人类认知功能以执行学习、推理和解决问题等任务的机器，尤其是电脑系统。 AI 的日益普及得益于其能够提高各行各业的效率、准确性和决策能力，尤其是能够以高精度自动化复杂数据分析。在生物技术领域，AI 可以显着加速药物研发，简化研究流程，并增强预测模型，最终有助于改善医疗保健结果。例如，2024年10月，英国科学、创新与技术部（DSIT）报告称，人工智慧活动显着增长，其中2023年人工智慧公司数量增长17%（新增543家），人工智慧创造的收益增长34%（新增36亿英镑），就业岗位增长29%（新增1.45万人），总增加价值202亿英镑（GVA257%），总增加127亿英镑增加25亿英镑），总增加127亿英镑增加25亿英镑增加25亿英镑），总增加127亿英镑增加25亿英镑增加25亿英镑），总增加价值25亿英镑增加25亿英镑（293亿英镑新增25亿英镑），附加价值毛额29%（新增1.45亿英镑），总增加价值21亿英镑增加25亿英镑（新25亿英镑），总增加价值25亿英镑增加25亿英镑增加25亿英镑），总增加120亿英镑增加25亿英镑。因此，人工智慧的日益普及正在推动人工智慧主导的生物技术市场的成长。

为了巩固市场地位，生物技术领域的主要企业正优先开发先进技术，例如基于人工智慧的抗体发现平台。这些平台利用人工智慧高效识​​别和优化治疗性抗体，加速药物开发，同时降低成本并改善临床疗效。例如，2023年2月，以色列创投工作室AION Labs推出了DenovAI，这是一个致力于从头发现治疗性抗体的创新平台。此尖端系统整合了机器学习和计算生物物理学，用于识别高亲和性候选抗体，从而提高了序列多样性、准确性并缩短了开发週期。 DenovAI代表了生物技术领域的重大飞跃，它促进了更快、更经济的药物发现，并提高了在各个疾病领域临床成功的几率。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球生物技术领域人工智慧的 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球生物技术人工智慧市场：成长率分析
  • 全球生物技术人工智慧市场表现：规模与成长，2019-2024
  • 全球生物技术人工智慧市场预测：2024-2029 年及 2034 年规模与成长
  • 生物技术领域的全球人工智慧总可寻址市场 (TAM)

第六章市场区隔

  • 全球生物技术市场人工智慧的组成部分、表现与预测（2019-2024、2024-2029、2034）
  • 软体
  • 硬体
  • 服务
  • 全球生物技术市场人工智慧的应用、表现和预测（2019-2024 年、2024-2029 年和 2034 年）
  • 药物研发
  • 临床试验和优化
  • 医学影像
  • 诊断
  • 其他用途
  • 全球生物技术市场人工智慧最终用户、绩效及预测（2019-2024、2024-2029、2034）
  • 製药公司
  • 生技公司
  • 学术研究所
  • 医疗保健提供者
  • 合约研究组织 (CRO) 和合约开发与製造组织 (CDMO)
  • 其他最终用户
  • 全球生物技术人工智慧市场：软体细分、类型、效能和预测，2019-2024 年、2024-2029 年、2034 年
  • 以人工智慧为基础的数据分析工具
  • 机器学习演算法
  • 生物资讯软体
  • 药物研发平台
  • 临床试验管理软体
  • 全球生物技术市场人工智慧、硬体细分、类型、性能和预测（2019-2024 年、2024-2029 年、2034 年）
  • 高效能运算（HPC）系统
  • AI一体化影像设备
  • 资料储存解决方案
  • 实验室自动化设备
  • 穿戴式健康监测设备
  • 全球生物技术人工智慧市场、服务细分、类型、表现及预测（2019-2024、2024-2029、2034）
  • 人工智慧实施与整合服务
  • 咨询和培训服务
  • 云端基础的人工智慧解决方案
  • 维护和支援服务
  • 客製化AI模型开发

第七章 区域和国家分析

  • 全球生物技术人工智慧市场各地区、表现及预测（2019-2024、2024-2029、2034）
  • 全球生物技术人工智慧市场（按国家、表现和预测），2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 生物技术领域的人工智慧：竞争格局
  • 生物技术领域的人工智慧市场：公司简介
    • Google LLC Overview, Products and Services, Strategy and Financial Analysis
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • International Business Machines Corporation（IBM）Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Bayer AG
  • Sanofi SA
  • Bristol-Myers Squibb Company
  • AstraZeneca Plc
  • Abbott Laboratories
  • Novartis AG
  • Roivant Sciences Ltd.
  • Gilead Sciences Inc.
  • NVIDIA Corporation
  • Amgen Inc.
  • Novo Nordisk A/S
  • Merck KGaA
  • Biogen Inc.
  • CareDx Inc.
  • Clario Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年生物技术领域的人工智慧：提供新机会的国家
  • 2029年生物技术领域的人工智慧：带来新机会领域
  • 2029年生物技术领域的人工智慧：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r35053

Artificial intelligence (AI) in biotechnology involves the application of machine learning and data-driven algorithms to interpret biological data and accelerate scientific research. It plays a vital role in areas such as drug discovery, genomics, diagnostics, and personalized medicine by recognizing patterns and forecasting outcomes. AI improves operational efficiency, reduces research costs, and provides deeper insights into complex biological systems, fueling innovation in healthcare and life sciences.

The primary components of AI in biotechnology include software, hardware, and services. Software in this context consists of sophisticated computational tools and algorithms that analyze biological data, simulate complex biological systems, and speed up processes such as drug development, genomic analysis, and precision medicine. It supports applications such as drug discovery and development, clinical trial optimization, medical imaging, diagnostics, and more, serving end users such as pharmaceutical and biotechnology companies, academic and research institutions, healthcare providers, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), and others.

The AI in biotechnology market research report is one of a series of new reports from The Business Research Company that provides AI in biotechnology market statistics, including AI in biotechnology industry global market size, regional shares, competitors with a AI in biotechnology market share, detailed AI in biotechnology market segments, market trends and opportunities, and any further data you may need to thrive in the AI in biotechnology industry. This AI in biotechnology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The AI in biotechnology market size has grown exponentially in recent years. It will grow from$4.46 billion in 2024 to $5.56 billion in 2025 at a compound annual growth rate (CAGR) of 24.8%. The growth during the historic period can be attributed to the rise in computational capabilities, the expansion of AI-driven drug discovery efforts, the increasing application of AI in microbiome research, the emergence of AI in regenerative medicine, and the growing adoption of AI in agricultural biotechnology.

The AI in biotechnology market size is expected to see exponential growth in the next few years. It will grow to$13.40 billion in 2029 at a compound annual growth rate (CAGR) of 24.6%. The growth in the forecast period can be attributed to the increasing adoption of AI technologies, rising investments in AI-biotech startups, growing use of AI in toxicology studies, the emergence of AI-driven predictive models in cancer research, and the expanding field of AI-driven drug repurposing. Key trends expected during this period include advancements in deep learning and neural networks, the integration of AI with genomics and proteomics, progress in AI-driven CRISPR gene editing, the use of AI in pharmacovigilance, and the development of AI-based companion diagnostics.

he growing adoption of artificial intelligence (AI) is anticipated to drive the expansion of the AI in biotechnology market. AI refers to the simulation of human cognitive functions by machines, particularly computer systems, to execute tasks such as learning, reasoning, and problem-solving. The rise in AI adoption is fueled by its ability to improve efficiency, precision, and decision-making across a wide range of industries, particularly through automating complex data analysis with high accuracy. In biotechnology, AI significantly accelerates drug discovery, streamlines research processes, and enhances predictive modeling, ultimately contributing to better healthcare outcomes. For example, in October 2024, the UK's Department for Science, Innovation & Technology (DSIT) reported a notable increase in AI activity in 2023, including a 17% rise in the number of AI companies (+543), a 34% boost in AI-generated revenue (+£3.6 billion), a 29% growth in employment (+14,500), and a nearly 57% increase in gross value added (GVA) (+£2.1 billion) compared to 2022. As a result, the expanding adoption of AI is propelling growth in the AI-driven biotechnology market.

Leading companies in the AI in biotechnology sector are prioritizing the development of advanced technologies, such as AI-powered platforms for antibody discovery, to strengthen their market position. These platforms leverage AI to efficiently identify and optimize therapeutic antibodies, accelerating drug development while reducing costs and improving clinical outcomes. For instance, in February 2023, AION Labs, a venture studio based in Israel, introduced DenovAI-an innovative platform dedicated to the de novo discovery of therapeutic antibodies. This state-of-the-art system integrates machine learning with computational biophysics to identify high-affinity antibody candidates, offering greater sequence diversity, enhanced precision, and shorter development cycles. DenovAI represents a significant leap in biotechnology, facilitating faster, more affordable drug discovery and increasing the likelihood of clinical success across various disease areas.

In February 2025, Incyte Corporation, a U.S.-based biopharmaceutical firm, entered into a strategic partnership with Genesis Therapeutics Inc. to harness the potential of AI in enhancing drug discovery efficiency. The partnership combines Incyte's deep expertise in drug development with Genesis Therapeutics' proprietary AI platform to accelerate the discovery and refinement of innovative small molecule therapies for targeted oncology treatments. Genesis Therapeutics Inc. is a U.S.-based biotechnology company that specializes in AI-powered drug discovery, aiming to revolutionize therapeutic development through advanced technological applications.

Major players in the ai in biotechnology market are Google LLC, Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., International Business Machines Corporation (IBM), Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Plc, Abbott Laboratories, Novartis AG, Roivant Sciences Ltd., Gilead Sciences Inc., NVIDIA Corporation, Amgen Inc., Novo Nordisk A/S, Merck KGaA, Biogen Inc., CareDx Inc., Clario Inc., BenevolentAI Limited, Recursion Pharmaceuticals Inc., Insilico Medicine Inc., and Genesis Therapeutics Inc.

North America was the largest region in the AI in biotechnology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in AI in biotechnology report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the AI in biotechnology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The AI in biotechnology market consists of revenues earned by entities providing services such as genomics analysis, precision medicine development, biomanufacturing optimization, and AI-driven diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in biotechnology market also includes sales of bioinformatics tools, automation systems, and AI-integrated laboratory equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

AI In Biotechnology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ai in biotechnology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ai in biotechnology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ai in biotechnology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Software; Hardware; Services
  • 2) By Application: Drug Discovery And Development; Clinical Trials And Optimization; Medical Imaging; Diagnostics; Other Applications
  • 3) By End User: Pharmaceutical Companies; Biotechnology Companies; Academic And Research Institutes; Healthcare Providers; Contract Research Organization (CRO) And Contract Development And Manufacturing Organization (CDMO); Other End Users
  • Subsegments:
  • 1) By Software: AI-Powered Data Analytics Tools: Machine Learning Algorithms; Bioinformatics Software; Drug Discovery Platforms; Clinical Trial Management Software
  • 2) By Hardware: High-Performance Computing (HPC) Systems; AI-Integrated Imaging Devices: Data Storage Solutions; Laboratory Automation Equipment; Wearable Health Monitoring Devices
  • 3) By Services: AI Implementation And Integration Services; Consulting And Training Services; Cloud-Based AI Solutions; Maintenance And Support Services; Custom AI Model Development
  • Companies Mentioned: Google LLC; Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; International Business Machines Corporation (IBM)
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. AI In Biotechnology Market Characteristics

3. AI In Biotechnology Market Trends And Strategies

4. AI In Biotechnology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global AI In Biotechnology Growth Analysis And Strategic Analysis Framework

  • 5.1. Global AI In Biotechnology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global AI In Biotechnology Market Growth Rate Analysis
  • 5.4. Global AI In Biotechnology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global AI In Biotechnology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global AI In Biotechnology Total Addressable Market (TAM)

6. AI In Biotechnology Market Segmentation

  • 6.1. Global AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software
  • Hardware
  • Services
  • 6.2. Global AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Discovery And Development
  • Clinical Trials And Optimization
  • Medical Imaging
  • Diagnostics
  • Other Applications
  • 6.3. Global AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic And Research Institutes
  • Healthcare Providers
  • Contract Research Organization (CRO) And Contract Development And Manufacturing Organization (CDMO)
  • Other End Users
  • 6.4. Global AI In Biotechnology Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • AI-Powered Data Analytics Tools
  • Machine Learning Algorithms
  • Bioinformatics Software
  • Drug Discovery Platforms
  • Clinical Trial Management Software
  • 6.5. Global AI In Biotechnology Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • High-Performance Computing (HPC) Systems
  • AI-Integrated Imaging Devices
  • Data Storage Solutions
  • Laboratory Automation Equipment
  • Wearable Health Monitoring Devices
  • 6.6. Global AI In Biotechnology Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • AI Implementation and Integration Services
  • Consulting and Training Services
  • Cloud-Based AI Solutions
  • Maintenance and Support Services
  • Custom AI Model Development

7. AI In Biotechnology Market Regional And Country Analysis

  • 7.1. Global AI In Biotechnology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global AI In Biotechnology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific AI In Biotechnology Market

  • 8.1. Asia-Pacific AI In Biotechnology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China AI In Biotechnology Market

  • 9.1. China AI In Biotechnology Market Overview
  • 9.2. China AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India AI In Biotechnology Market

  • 10.1. India AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan AI In Biotechnology Market

  • 11.1. Japan AI In Biotechnology Market Overview
  • 11.2. Japan AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia AI In Biotechnology Market

  • 12.1. Australia AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia AI In Biotechnology Market

  • 13.1. Indonesia AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea AI In Biotechnology Market

  • 14.1. South Korea AI In Biotechnology Market Overview
  • 14.2. South Korea AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe AI In Biotechnology Market

  • 15.1. Western Europe AI In Biotechnology Market Overview
  • 15.2. Western Europe AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK AI In Biotechnology Market

  • 16.1. UK AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany AI In Biotechnology Market

  • 17.1. Germany AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France AI In Biotechnology Market

  • 18.1. France AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy AI In Biotechnology Market

  • 19.1. Italy AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain AI In Biotechnology Market

  • 20.1. Spain AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe AI In Biotechnology Market

  • 21.1. Eastern Europe AI In Biotechnology Market Overview
  • 21.2. Eastern Europe AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia AI In Biotechnology Market

  • 22.1. Russia AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America AI In Biotechnology Market

  • 23.1. North America AI In Biotechnology Market Overview
  • 23.2. North America AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA AI In Biotechnology Market

  • 24.1. USA AI In Biotechnology Market Overview
  • 24.2. USA AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada AI In Biotechnology Market

  • 25.1. Canada AI In Biotechnology Market Overview
  • 25.2. Canada AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America AI In Biotechnology Market

  • 26.1. South America AI In Biotechnology Market Overview
  • 26.2. South America AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil AI In Biotechnology Market

  • 27.1. Brazil AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East AI In Biotechnology Market

  • 28.1. Middle East AI In Biotechnology Market Overview
  • 28.2. Middle East AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa AI In Biotechnology Market

  • 29.1. Africa AI In Biotechnology Market Overview
  • 29.2. Africa AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. AI In Biotechnology Market Competitive Landscape And Company Profiles

  • 30.1. AI In Biotechnology Market Competitive Landscape
  • 30.2. AI In Biotechnology Market Company Profiles
    • 30.2.1. Google LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. International Business Machines Corporation (IBM) Overview, Products and Services, Strategy and Financial Analysis

31. AI In Biotechnology Market Other Major And Innovative Companies

  • 31.1. Bayer AG
  • 31.2. Sanofi S.A.
  • 31.3. Bristol-Myers Squibb Company
  • 31.4. AstraZeneca Plc
  • 31.5. Abbott Laboratories
  • 31.6. Novartis AG
  • 31.7. Roivant Sciences Ltd.
  • 31.8. Gilead Sciences Inc.
  • 31.9. NVIDIA Corporation
  • 31.10. Amgen Inc.
  • 31.11. Novo Nordisk A/S
  • 31.12. Merck KGaA
  • 31.13. Biogen Inc.
  • 31.14. CareDx Inc.
  • 31.15. Clario Inc.

32. Global AI In Biotechnology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The AI In Biotechnology Market

34. Recent Developments In The AI In Biotechnology Market

35. AI In Biotechnology Market High Potential Countries, Segments and Strategies

  • 35.1 AI In Biotechnology Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 AI In Biotechnology Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 AI In Biotechnology Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer